1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

26 Jul 2024
Admin
News Article

Eisai and EcoNaviSta Forge Business Partnership to Develop a Dementia Care Ecosystem

Eisai and EcoNaviSta Forge Business Partnership to Develop a Dementia Care Ecosystem and Initiate Collaboration

Overview

Eisai Co., Ltd. (Tokyo, CEO: Haruo Naito) and EcoNaviSta Inc. (Tokyo, President: Kimihito Watanabe) have formed a strategic alliance to tackle dementia, a significant challenge in Japan’s aging population.

About Eisai

Eisai, a leader in dementia research and awareness, and EcoNaviSta, known for its SaaS-based care home monitoring systems, will collaborate to conduct a proof-of-concept study.
This initiative will combine Eisai’s NouKNOW®, a digital brain health assessment tool, with EcoNaviSta’s Life Rhythm Navi®, a system that analyzes health data from sleep and lifestyle patterns, along with EcoNaviSta’s patented Dementia Prediction Model (JP Patent 7017740).

Collab to Detect Early Signs of Cognitive Decline

Many elderly individuals in Japan move to independent living facilities while still relatively healthy, which can result in extended stays with minimal interaction with care staff.
This often delays the detection of cognitive issues such as Mild Cognitive Impairment (MCI) or dementia.
The collaboration aims to use these tools to identify early signs of cognitive decline, potentially detecting MCI and dementia before they advance significantly.
Additionally, the partnership will explore the potential use of the dementia prediction model in home care settings.

Eisai’s Mission

Eisai’s mission is to prioritize patient needs and enhance healthcare outcomes through innovation and collaboration.
The company focuses on neurology, oncology, and global health, with a goal of addressing unmet medical needs through partnerships and new solutions.

EcoNaviSta’s Objective

EcoNaviSta’s objective is to improve health and well-being through advanced sleep analysis technology.
Their AI model, which predicts health changes based on detailed sleep and lifestyle data, plays a key role in their services.
They are committed to advancing digital solutions in nursing care and addressing societal challenges with their technology.

This partnership between Eisai and EcoNaviSta is dedicated to advancing dementia care and developing a supportive ecosystem for those affected by cognitive decline.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!